Investors Menu
Tilray, Inc. Releases 11 Million Shares From Lock-Up Agreement
NANAIMO, British Columbia --(BUSINESS WIRE)--Mar. 31, 2020-- Tilray, Inc. (NASDAQ: TLRY) (“Tilray”), a global pioneer in cannabis production, research, cultivation and distribution, today announced that the Board of Directors of Tilray unanimously approved the pro rata release of 11 million shares
March 31, 2020
Tilray, Inc. Announces Pricing of its $90.4 Million Registered Offering
NANAIMO, British Columbia --(BUSINESS WIRE)-- Tilray, Inc. (“ Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today that it has priced an underwritten registered offering of 7,250,000 shares of its Class 2 common
March 13, 2020
Tilray® Expands Global Leadership Team with New COO and CFO
Former Revlon executive, Jon Levin , joins as Chief Operating Officer and former Molson Coors and Pharmaca executive, Michael Kruteck joins as Chief Financial Officer Current Tilray CFO, Mark Castaneda , to stay on in strategic business development role NANAIMO, British Columbia --(BUSINESS
January 14, 2020
Tilray, Inc. to Present at the 2020 ICR Conference
NANAIMO, British Columbia --(BUSINESS WIRE)--Jan. 7, 2020-- Tilray, Inc. , (“ Tilray” or “the Company”) (Nasdaq: TLRY), a global leader in medical cannabis research, cultivation, production and distribution, today announced that Brendan Kennedy , President and Chief Executive Officer, will present
January 7, 2020
Tilray Exports First-Ever Shipment of Medical Cannabis Allowed Into Israel
Company signs 2.5 tonne strategic partnership agreement with Canndoc to address growing demand for medical cannabis products in Israeli market Export to Israel originates from Tilray’s Portugal facility; Tilray now exports medical cannabis to 15 countries worldwide NANAIMO, British
January 2, 2020